Nebulizer


Combined with:

Advair Diskus 100/50

Indications and Reactions:

Role Indications Reactions
Secondary
Chronic Obstructive Pulmonary Disease 36.1%
Asthma 21.3%
Product Used For Unknown Indication 14.8%
Smoking Cessation Therapy 13.1%
Drug Use For Unknown Indication 11.5%
Hypertension 1.6%
Primary Immunodeficiency Syndrome 1.6%
Treatment Noncompliance 25.0%
Productive Cough 10.7%
Drug Ineffective 7.1%
Therapeutic Response Decreased 7.1%
Atelectasis 3.6%
Dyspnoea 3.6%
Inflammation 3.6%
Infusion Site Swelling 3.6%
Local Swelling 3.6%
Lung Disorder 3.6%
Pharmaceutical Product Complaint 3.6%
Pneumonia 3.6%
Product Quality Issue 3.6%
Sputum Discoloured 3.6%
Tardive Dyskinesia 3.6%
Upper-airway Cough Syndrome 3.6%
Wheezing 3.6%
Wrong Drug Administered 3.6%
Concomitant
Chronic Obstructive Pulmonary Disease 24.2%
Asthma 18.6%
Drug Use For Unknown Indication 14.8%
Product Used For Unknown Indication 13.6%
Emphysema 3.4%
Hypertension 3.4%
Rheumatoid Arthritis 2.7%
Gastrooesophageal Reflux Disease 2.4%
Diabetes Mellitus 2.2%
Pain 2.2%
Dyspnoea 2.2%
Cardiac Disorder 1.8%
Blood Cholesterol Increased 1.7%
Anxiety 1.3%
Hypothyroidism 1.2%
Depression 1.1%
Cardiac Failure Congestive 1.1%
Bronchitis 0.8%
Crohn's Disease 0.8%
Heart Rate Irregular 0.7%
Product Quality Issue 20.3%
Wheezing 12.2%
Pneumonia 9.3%
Drug Ineffective 8.9%
Dyspnoea 8.0%
Vomiting 5.9%
Dysphonia 3.8%
Weight Increased 3.8%
Chronic Obstructive Pulmonary Disease 3.0%
Therapeutic Response Decreased 3.0%
Visual Impairment 3.0%
Cough 2.1%
Death 2.1%
Drug Dose Omission 2.1%
Incorrect Route Of Drug Administration 2.1%
Lung Disorder 2.1%
Off Label Use 2.1%
Pneumonitis 2.1%
Pulmonary Congestion 2.1%
Sinusitis 2.1%

Drug Data